Engineering strategies to enhance nanoparticle-mediated oral delivery.
about
RNA interference technology to control pest sea lampreys--a proof-of-conceptPolymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruitDesign and synthesis of pH-sensitive polymeric micelles for oral delivery of poorly water-soluble drugs.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.Expert opinion: Responsive polymer nanoparticles in cancer therapypH-Responsive nanoparticles for drug delivery.Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.Microscale oral delivery devices incorporating nanoparticles.Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale.Basics and recent advances in peptide and protein drug delivery.Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.
P2860
Q28539579-00DF940B-ED44-416D-AE04-3BAE777CC764Q30451024-46ED7612-7556-41F7-A6CB-A3B479527E4AQ30573518-B696B198-8712-4AD2-9D8B-6302921FB165Q31110527-A26504EA-2410-4D28-A6F7-B0A4D7EAF439Q34030709-EF152D0E-6F15-4FDC-8190-B37AAA34700DQ34354205-43A9F30F-F070-469F-9C31-A1F9A8CD26A3Q35124399-9497D5A9-875E-44E7-AAC9-D464E9BD5518Q35718515-D7839145-C7F3-4487-A5D4-C16A00E11E41Q36047019-9E423BFB-7399-4ADF-B8EA-79FB9A175921Q36755475-B9988804-F7EF-4285-8B4F-8C309DAC8976Q37194117-70336588-8A6B-4C13-B198-D4B58904B0CFQ37690689-2BF09E9A-2824-4B38-8BD5-EF0599A1F84DQ37877717-732235A4-8ABB-48F1-87E4-7E085D127088Q38162494-9544F34C-52EE-4EA5-B883-72D3A94CF465Q42380474-368765EB-E0BA-448C-A992-BE9C095D2A01Q47163895-6E95778D-8D59-4323-BA7C-966B58F16822
P2860
Engineering strategies to enhance nanoparticle-mediated oral delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@en
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@nl
type
label
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@en
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@nl
prefLabel
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@en
Engineering strategies to enhance nanoparticle-mediated oral delivery.
@nl
P2860
P1476
Engineering strategies to enhance nanoparticle-mediated oral delivery
@en
P2093
Yvonne J Yamanaka
P2860
P304
P356
10.1163/156856208786440479
P50
P577
2008-01-01T00:00:00Z